Weight-Loss Billing and Coding 2026: Obesity ICD-10 Codes

Last updated: September 2026

Choosing the correct obesity ICD-10 code is the foundation of getting a medical weight-loss program paid — and it is where many practices stumble. Coding for obesity looks simple until a claim is denied for a missing diagnosis, a BMI code used in the wrong position, or documentation that does not support medical necessity. This 2026 guide walks through the obesity diagnosis and BMI codes, the E/M and counseling CPT codes, the documentation that holds up, the common denials, and how cash-pay and insurance models compare.

It puts the business side of our complete prescriber’s guide to GLP-1 medications for weight management into practice, so a clinically excellent program is also a financially sustainable one.

Key Takeaways

Obesity ICD-10 Coding (E66.x) and BMI Z-Codes

Accurate diagnosis coding starts with the E66 category for overweight and obesity, which was expanded with class-based codes that let you specify severity. Below are the commonly used obesity ICD-10 codes for 2026.

BMI is reported separately with Z68 codes — and the sequencing rule matters. Adult BMI codes run from Z68.1 through Z68.45 (for example, Z68.41 for a BMI of 40.0–44.9), with pediatric percentile codes in the Z68.5 series. Critically, Z68 BMI codes are secondary diagnoses only; they support an obesity diagnosis but cannot stand alone, and a BMI value in the chart is not enough on its own — the provider must document the obesity diagnosis itself (Centers for Disease Control and Prevention, 2026). Code the obesity from E66 as the diagnosis, then add the Z68 BMI code as a secondary code.

E/M and Behavioral-Counseling CPT Codes

The diagnosis codes tell the payer why; the procedure codes tell them what you did. Most weight-management visits are billed with standard evaluation and management (E/M) office-visit codes (99202–99215), selected by medical decision-making or total time.

Dedicated counseling has its own codes. Preventive behavior-change counseling for an individual is reported with the 99401–99404 series by time, and Medicare’s intensive behavioral therapy (IBT) for obesity uses HCPCS codes (Centers for Medicare & Medicaid Services, 2026; American Medical Association, 2026).

Match the code to the actual service and time documented, and be mindful of payer-specific rules — Medicare’s IBT benefit, for instance, has its own eligibility and frequency conditions that differ from commercial preventive-counseling coverage.

How the Medicare IBT Benefit Actually Works

The IBT benefit is more prescriptive than most practices expect, and its conditions are where the money is won or lost. Coverage requires a BMI of 30 or greater. The counseling must be delivered in a primary care setting by a qualified primary care physician or practitioner — or incident to their services in a non-facility setting — and follow the five-A framework (assess, advise, agree, assist, arrange). The visit schedule is fixed: weekly for the first month, every other week for months two through six, then monthly for months seven through twelve, and that final stretch is earned. A beneficiary must have lost at least 3 kg (about 6.6 lb) at the six-month reassessment to continue; if not, counseling pauses and can be reattempted after six months. Coinsurance and the deductible are waived, which makes it one of the few weight-management services a Medicare patient pays nothing for (Noridian Healthcare Solutions, 2026).

New for 2026: Remote Monitoring Codes That Fit Weight Programs

The CPT 2026 code set, effective January 1, added remote physiologic monitoring codes that suit weight-management programs far better than the old ones did. CPT 99445 covers the initial device supply with daily recordings over 2–15 days in a 30-day period — previously, a program whose patient transmitted weights for only part of the month could bill nothing, because 99454 requires 16–30 days. CPT 99470 covers the first 10 minutes of monthly RPM treatment-management time with one real-time interactive contact, where 99457 requires 20. For a program built on connected scales and short check-ins, those two codes turn previously unbillable work into a payable service. Medicare rates for both are modest — roughly $47 and $26 nationally before locality adjustment — so treat them as a margin improvement on work you already do, not a revenue line of their own.

Medicare’s GLP-1 Bridge Program: What Changed on July 1, 2026

For years, the flat answer to “does Medicare cover weight-loss drugs?” was no — Part D statutorily excludes agents used only for weight loss. That is no longer the whole answer, and any billing guidance written before mid-2026 is now out of date on this point.

Through the temporary GLP-1 Bridge demonstration, Medicare Part D enrollees can now obtain Wegovy® (injection or tablet), the Zepbound® KwikPen®, or Foundayo™ (orforglipron) for a fixed $50 monthly copay for a 28- or 30-day supply. Eligibility runs on BMI plus risk: a BMI of 35 or greater; or 30 or greater with a condition such as heart failure, uncontrolled hypertension, or chronic kidney disease; or 27 or greater with prediabetes, prior myocardial infarction or stroke, or peripheral artery disease. Patients must be 18 or older and commit to lifestyle change, and every fill requires an approved prior authorization submitted by the prescriber (Centers for Medicare & Medicaid Services, 2026). Note the fine print that surprises patients: the $50 does not count toward the Part D deductible or the annual out-of-pocket cap, and single-dose Zepbound® pens and vials are excluded — only the KwikPen® qualifies, which makes the choice between tirzepatide and semaglutide a coverage question as well as a clinical one for this population.

Two dates belong on your operational calendar. The Bridge program is scheduled to end December 31, 2027, with a successor program slated to follow in 2028; and state Medicaid programs may opt in on their own timelines between May 1, 2027 and January 1, 2028, so the Medicaid answer will stay state-by-state well into 2027. Until then, treat Bridge eligibility as a screening question at intake rather than an assumption either way.

Documentation That Supports Medical Necessity

Codes are only as strong as the documentation behind them. Payers reimburse for medically necessary care, so the record must connect the diagnosis, the service, and the clinical rationale.

At minimum, document the obesity diagnosis explicitly (not just a BMI value), the BMI and any weight-related comorbidities such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea, and the specifics of the encounter — what was assessed, counseled, and planned, plus the time spent when billing time-based codes. Tie each service to the diagnosis it addresses, and favor the most specific code available — the class-based E66.811/812/813 codes paint a clearer clinical picture than E66.9 (unspecified) and better withstand review. This is the same medical-necessity logic that underlies coverage for anti-obesity medications, where payers typically look for a qualifying BMI (commonly 30 or greater, or 27 or greater with a comorbidity) and often documented lifestyle efforts — the same ground your patient-selection and screening workup already covers, which is why a structured intake form does double duty as billing evidence. Thorough documentation is what turns a correct code into a paid claim, and specificity in both the code and the note is what keeps it from coming back.

Common Denials and How to Avoid Them

Most weight-management denials trace to a short list of avoidable errors. Knowing them lets you build them out of your workflow.

The frequent culprits are a BMI (Z68) code used as a primary diagnosis instead of secondary; a missing or non-specific obesity diagnosis; documentation that records a BMI number but never states the obesity diagnosis; a mismatch between the service billed and the diagnosis; and missing prior authorization for a covered anti-obesity medication. A distinct category is the flat exclusion — many plans simply do not cover weight-loss drugs or services, in which case no coding fixes it and a cash-pay path is the answer. For medications specifically, an efficient prior-authorization process prevents a large share of denials; our GLP-1 prior authorization playbook covers that workflow in detail. Scrubbing claims for correct code sequencing and complete documentation before submission is the single highest-yield habit.

Cash-Pay vs. Insurance Program Models

Because coverage for weight management is so inconsistent, the choice of business model is as consequential as the coding itself. Many successful programs run on a cash-pay or membership basis, with transparent pricing for visits and counseling and the medication obtained through the patient’s pharmacy benefit where possible. This sidesteps the coverage patchwork and the administrative load of prior authorizations, and it pairs naturally with other cash-pay services.

An insurance-based model can widen access but demands disciplined coding, medical-necessity documentation, and a prior-authorization engine to function. Many practices run a hybrid — billing insurance for the medical visit and evaluation where covered, while offering cash-pay program elements around it. Whichever you choose, clear financial disclosures and consistent coding practices protect both the patient and the practice, and the operational blueprint for building the program itself should be settled before the first claim goes out. Building a compliant, financially sound program end to end is exactly what IAPAM’s medical weight-loss program certification is designed to teach.

Frequently Asked Questions

What is the ICD-10 code for obesity?

It depends on severity. Common 2026 codes include E66.9 (obesity, unspecified), E66.811, E66.812 and E66.813 for class 1, 2 and 3 obesity by BMI, E66.01 (morbid obesity due to excess calories), and E66.3 (overweight). Code the specific obesity diagnosis and add a Z68 BMI code as secondary.

Can I use a BMI (Z68) code as the primary diagnosis?

No. Z68 BMI codes are secondary diagnoses only. They support an obesity diagnosis but cannot stand alone, and a BMI value alone is insufficient — the provider must document the obesity diagnosis, coded from the E66 category. The one place a BMI code takes center stage is the Medicare IBT claim, which is expected to carry a Z68.30 through Z68.45 code alongside the documented diagnosis.

Which CPT codes are used for obesity counseling?

Individual preventive behavior-change counseling uses 99401 through 99404 by time. Medicare’s intensive behavioral therapy for obesity uses HCPCS G0447 (individual, 15 minutes) and G0473 (group). Standard E/M office-visit codes (99202 through 99215) cover most medical visits.

Does Medicare cover GLP-1 medications for weight loss in 2026?

Partly, and only through a temporary pathway. Since July 1, 2026, the Medicare GLP-1 Bridge program covers Wegovy® (injection or tablet), Zepbound® KwikPen® and Foundayo™ for Part D enrollees who meet the BMI and comorbidity criteria and have prior authorization, at a fixed $50 monthly copay. The program is scheduled to run through December 31, 2027. Outside it, Part D still excludes drugs used only for weight loss.

Why do weight-loss claims get denied?

Common reasons include a BMI code used as primary instead of secondary, a missing or non-specific obesity diagnosis, documentation lacking the stated diagnosis, service-diagnosis mismatch, missing prior authorization, or a plan that excludes weight-loss coverage entirely.

What documentation supports medical necessity for weight management?

An explicit obesity diagnosis, the BMI and any weight-related comorbidities, the specifics of what was assessed and counseled, and time spent for time-based codes — each service tied to the diagnosis it addresses. Payers often also look for a qualifying BMI and documented lifestyle efforts for medication coverage.

Should my weight-loss program be cash-pay or insurance-based?

Both models work. Cash-pay or membership avoids the coverage patchwork and prior-authorization burden and pairs well with other cash services; an insurance model widens access but requires disciplined coding and a PA workflow. Many practices run a hybrid.

Conclusion

Sound billing for a weight-loss program comes down to fundamentals: pick the specific obesity ICD-10 code, sequence the BMI Z-code as secondary, match the CPT or HCPCS code to the documented service, and back it all with medical-necessity documentation. Get those right and most denials disappear; where a plan simply excludes coverage, a cash-pay model keeps the program viable. Then diary the two dates that move the ground under you — October 1 for the annual ICD-10 update, and the Bridge program’s December 2027 sunset.

For the clinical side of the program, see our complete prescriber’s guide to GLP-1 medications. And to build a compliant, profitable medical weight-loss program end to end, IAPAM’s GLP-1 certification for physicians and NPs — backed by more than 20 years of training healthcare professionals and over 6,300 five-star reviews — provides the clinical and business frameworks. Clinicians expanding a cash-pay practice often add aesthetic services alongside weight management; the same foundation supports Botox® training for nurse practitioners.

Explore GLP-1 Certification Training →

References

Disclaimer: This article is for informational and educational purposes only and does not constitute billing, coding, or legal advice. Code sets and payer policies change at least annually; always verify current codes against the official ICD-10-CM, CPT, and HCPCS sources and the specific payer’s rules before submitting claims.